Education
About Us
Working with TipRanks
Follow Us
Selvita SA (PL:SLV)
:SLV
SLV Stock Chart & Stats
zł46.50
--
Market closed
zł46.50
--
Day’s Range― - ―
52-Week Rangezł26.50 - zł50.80
Previous CloseN/A
VolumeN/A
Average Volume (3M)40.05K
Market Cap
zł853.53M
Enterprise ValueN/A
Total Cash (Recent Filing)zł17.02M
Total Debt (Recent Filing)zł190.33M
Price to Earnings (P/E)―
Beta0.80
Next Earnings
Mar 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding18,355,474
10 Day Avg. Volume21,446
30 Day Avg. Volume40,050
Financial Highlights & Ratios
PEG Ratio1.37
Price to Book (P/B)2.82
Price to Sales (P/S)2.66
P/FCF Ratio20.03
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
SLV FAQ
What was Selvita SA’s price range in the past 12 months?
Selvita SA lowest stock price was zł26.50 and its highest was zł50.80 in the past 12 months.
What is Selvita SA’s market cap?
Selvita SA’s market cap is zł853.53M.
When is Selvita SA’s upcoming earnings report date?
Selvita SA’s upcoming earnings report date is Mar 26, 2026 which is in 73 days.
How were Selvita SA’s earnings last quarter?
Selvita SA released its earnings results on Nov 20, 2025. The company reported -zł0.051 earnings per share for the quarter, missing the consensus estimate of N/A by -zł0.051.
Is Selvita SA overvalued?
According to Wall Street analysts Selvita SA’s price is currently Overvalued.
Does Selvita SA pay dividends?
Selvita SA does not currently pay dividends.
What is Selvita SA’s EPS estimate?
Selvita SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Selvita SA have?
Selvita SA has 18,355,474 shares outstanding.
What happened to Selvita SA’s price movement after its last earnings report?
Selvita SA reported an EPS of -zł0.051 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 8.959%.
Which hedge fund is a major shareholder of Selvita SA?
Currently, no hedge funds are holding shares in PL:SLV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Selvita SA
Selvita S.A. operates as a contract research organization in Poland, rest of Europe, the United States, and internationally. It operates in two segments, Contract Research Organization (CRO) services, and Bioinformatics. The company offers drug discovery services in the areas of assay development and screening, medicinal and synthetic chemistry, computer-aided drug design/ artificial intelligence, structural biology, in vitro/ In Vivo pharmacology, ADME/DMPK and analytical testing. It also provides pharma services in the field of drug testing and bioanalytical analysis, including development and optimization, validation and transfer, stability studies, quality control, and regulatory aspects support services. In addition, the company offers research and development services in the areas of process research, laboratory scale custom synthesis of NCEs, industrial chemistry, and synthesis of isotopically labelled compounds, as well as other services for the agrochemical industry. Further, it provides bio-data science and advanced software services to data-driven life science and healthcare organizations. Selvita S.A. was founded in 2007 and is headquartered in Krakow, Poland.
Technical Analysis
―
Ryvu Therapeutics SA
―
Celon Pharma SA
―
Captor Therapeutics SA
―
OncoArendi Therapeutics SA
―